The National Football League (NFL) announced Novartis as its first-ever corporate pharmaceutical partner on March 13.

The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...

The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with a ...

American football’s elite National Football League (NFL) has brought in US medicine company Novartis as the property's ...

Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...

The NFL have signed its first-ever pharmaceutical partner in a multi-year deal with Novartis to focus on the NFL’s health ...

Novartis, a leading innovative medicines company, and the National Football League (NFL) announced an unprecedented partnership that names Novartis as the official first-in-category corporate ...

The NFL has inked a multi-year deal with pharmaceutical giant Novartis, marking its first such partnership. This ...

The NFL did not allow pharmaceutical sponsorships for teams until 2003. The Novartis deal goes beyond the NFL's early sponsorships in the health sector, however, seeing the company serve as a ...

Novartis, a pharmaceuticals company, and the National Football League have announced an unprecedented partnership that names ...